Exciton binding regulation in oxygen-independent tumor photooxidation enables synchronous photoluminescence for cancer theranostics
In the authors' words
Overcoming the accuracy-efficiency trade-off in light-driven cancer therapy remains a significant challenge for theranostics. Herein, we report a fullerene-loaded heptazine‒perylene (HP/C60) nanopolymer that enables the oxygen-independent oxidation of intracellular biomolecules via photogenerated hole transfer (+1.53 V vs. NHE). Concurrently, HP/C60 facilitates cancer theranostics through spatiotemporal fluorescence imaging with resistance to photobleaching. By precisely tuning the exciton binding energy through controlled interface-induced charge delocalization, we optimize the ratio of exciton recombination and dissociation pathways, enabling the rational allocation of photoluminescence for high-contrast bioimaging and photooxidation for efficient tumor elimination. A 20-minute red light irradiation of HP/C60 is sufficient to initiate the complete ablation of solid tumors of female mice, with the entire therapeutic process monitored via real-time fluorescence imaging. This work establishes exciton management as a universal design principle to synchronize photooxidation and photoluminescence and supports the development of organic semiconductors for cancer theranostics. Overcoming the accuracy-efficiency trade-off in light-driven cancer therapy is challenging for developing theranostic systems. Here, the authors report a fullerene-loaded heptazine‒perylene nanopolymer that facilitates cancer theranostics through the oxygen-independent oxidation of intracellular biomolecules, and through spatiotemporal fluorescence imaging with resistance to photobleaching.
Appeared: Thursday, November 19. Nature Communications. Peer-reviewed journal.